Contents

Current Cancer Drug Targets, Volume 13 - Number 2

Editorial

Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer)

, 13(2): 117 - 120

Jiezhong Chen


DOI: 10.2174/1568009611313020001




Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer

, 13(2): 121 - 125

Zhaode Bu and Jiafu Ji


DOI: 10.2174/1568009611313020002




Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma

, 13(2): 126 - 142

Daniel C. Cho and James W. Mier


DOI: 10.2174/1568009611313020003




Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer

, 13(2): 143 - 156

Jianghong Wu, Chen Chen and Kong-Nan Zhao


DOI: 10.2174/1568009611313020004




The PI3 Kinase Signaling Pathway in Prostate Cancer

, 13(2): 157 - 164

Aymen A. Elfiky and Zhenyang Jiang


DOI: 10.2174/1568009611313020005




Studies of NVP-BEZ235 in Melanoma

, 13(2): 165 - 174

Joshua A. Sznol, Lucia B. Jilaveanu and Harriet M. Kluger


DOI: 10.2174/1568009611313020006




Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer

, 13(2): 175 - 187

Xiaobei Zhang, Xi-ru Li and Jin Zhang


DOI: 10.2174/1568009611313020007




Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling

, 13(2): 188 - 204

Thomas W. Grunt and Gabriella L. Mariani


DOI: 10.2174/1568009611313020008




Current and Potential Treatments for Cervical Cancer

, 13(2): 205 - 220

Grace P.C. Yee, Paul de Souza and Levon M. Khachigian


DOI: 10.2174/1568009611313020009




The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas

, 13(2): 221 - 231

Hailin Tang, Yanhui Bian, Chaofeng Tu, Zeyou Wang, Zhibin Yu, Qing Liu, Gang Xu, Minghua Wu and Guiyuan Li


DOI: 10.2174/1568009611313020010




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science